Acquiring Swiss Parenterals will bolster the company's domestic presence with a new injectables-focused branded formulations business and enhance reach in emerging markets
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.